Griffiths, Robert I.; Barron, Richard L.; Gleeson, … - In: PharmacoEconomics 30 (2012) 2, pp. 103-118
Background:Background: Granulocyte-colony stimulating factor (G-CSF) reduces the risk of severe neutropenia associated with chemotherapy, but its cost implications following chemotherapy are unknown. Abstract: Objective:Objective: Our objective was to examine associations between G-CSF use and...